These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 28040194

  • 21. Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada--occurrence and treatment efficiency.
    Kleywegt S, Pileggi V, Yang P, Hao C, Zhao X, Rocks C, Thach S, Cheung P, Whitehead B.
    Sci Total Environ; 2011 Mar 15; 409(8):1481-8. PubMed ID: 21315426
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. De facto Water Reuse: Investigating the Fate and Transport of Chemicals of Emerging Concern from Wastewater Discharge through Drinking Water Treatment Using Non-targeted Analysis and Suspect Screening.
    Brunelle LD, Batt AL, Chao A, Glassmeyer ST, Quinete N, Alvarez DA, Kolpin DW, Furlong ET, Mills MA, Aga DS.
    Environ Sci Technol; 2024 Feb 06; 58(5):2468-2478. PubMed ID: 38252456
    [Abstract] [Full Text] [Related]

  • 24. Colloids as a sink for certain pharmaceuticals in the aquatic environment.
    Maskaoui K, Zhou JL.
    Environ Sci Pollut Res Int; 2010 May 06; 17(4):898-907. PubMed ID: 20024675
    [Abstract] [Full Text] [Related]

  • 25. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance.
    Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT.
    Environ Sci Technol; 2002 Mar 15; 36(6):1202-11. PubMed ID: 11944670
    [Abstract] [Full Text] [Related]

  • 26. Pharmaceuticals in tap water: human health risk assessment and proposed monitoring framework in China.
    Leung HW, Jin L, Wei S, Tsui MM, Zhou B, Jiao L, Cheung PC, Chun YK, Murphy MB, Lam PK.
    Environ Health Perspect; 2013 Jul 15; 121(7):839-46. PubMed ID: 23665928
    [Abstract] [Full Text] [Related]

  • 27. Occurrences of pharmaceuticals in drinking water sources of major river watersheds, China.
    Sun J, Luo Q, Wang D, Wang Z.
    Ecotoxicol Environ Saf; 2015 Jul 15; 117():132-40. PubMed ID: 25847753
    [Abstract] [Full Text] [Related]

  • 28. Monitoring for contaminants of emerging concern in drinking water using POCIS passive samplers.
    Metcalfe C, Hoque ME, Sultana T, Murray C, Helm P, Kleywegt S.
    Environ Sci Process Impacts; 2014 Mar 15; 16(3):473-81. PubMed ID: 24531237
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The importance of quality control in validating concentrations of contaminants of emerging concern in source and treated drinking water samples.
    Batt AL, Furlong ET, Mash HE, Glassmeyer ST, Kolpin DW.
    Sci Total Environ; 2017 Feb 01; 579():1618-1628. PubMed ID: 28040193
    [Abstract] [Full Text] [Related]

  • 31. Occurrence and risk assessment of pharmaceuticals in surface waters of the Middle East and North Africa: A review.
    Mheidli N, Malli A, Mansour F, Al-Hindi M.
    Sci Total Environ; 2022 Dec 10; 851(Pt 2):158302. PubMed ID: 36030863
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Human health screening and public health significance of contaminants of emerging concern detected in public water supplies.
    Benson R, Conerly OD, Sander W, Batt AL, Boone JS, Furlong ET, Glassmeyer ST, Kolpin DW, Mash HE, Schenck KM, Simmons JE.
    Sci Total Environ; 2017 Feb 01; 579():1643-1648. PubMed ID: 28040195
    [Abstract] [Full Text] [Related]

  • 36. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L, Smyth SA, Sarafin K, Kleywegt S, Toito J, Peart T, Lee B, Servos M, Beland M, Seto P.
    Sci Total Environ; 2006 Aug 31; 367(2-3):544-58. PubMed ID: 16697441
    [Abstract] [Full Text] [Related]

  • 37. Wastewater reuse and pharmaceutical pollution in agriculture: Uptake, transport, accumulation and metabolism of pharmaceutical pollutants within plants.
    Mosharaf MK, Gomes RL, Cook S, Alam MS, Rasmusssen A.
    Chemosphere; 2024 Sep 31; 364():143055. PubMed ID: 39127189
    [Abstract] [Full Text] [Related]

  • 38. Evaluating the extent of pharmaceuticals in surface waters of the United States using a National-scale Rivers and Streams Assessment survey.
    Batt AL, Kincaid TM, Kostich MS, Lazorchak JM, Olsen AR.
    Environ Toxicol Chem; 2016 Apr 31; 35(4):874-81. PubMed ID: 26562077
    [Abstract] [Full Text] [Related]

  • 39. Pharmaceutical manufacturing facility discharges can substantially increase the pharmaceutical load to U.S. wastewaters.
    Scott TM, Phillips PJ, Kolpin DW, Colella KM, Furlong ET, Foreman WT, Gray JL.
    Sci Total Environ; 2018 Sep 15; 636():69-79. PubMed ID: 29704718
    [Abstract] [Full Text] [Related]

  • 40. Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents.
    Phillips PJ, Smith SG, Kolpin DW, Zaugg SD, Buxton HT, Furlong ET, Esposito K, Stinson B.
    Environ Sci Technol; 2010 Jul 01; 44(13):4910-6. PubMed ID: 20521847
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.